首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1373385

全球安全注射器市場 - 2023-2030

Global Safety Syringes Market - 2023-2030

出版日期: 2023年10月18日 | 出版商:

DataM Intelligence | 英文 187 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

安全注射器是一種具有內建安全機制的注射器，可降低醫護人員和其他人被針刺傷的風險。安全注射器上的針頭可以是可拆卸的，也可以是永久固定的。

安全針頭的功能與安全注射器相同，但保護機構是針頭的一部分，而不是注射器的一部分。最有效的安全注射器具有重複使用和防止針刺傷的功能。安全注射器是另外包含安全機構的注射器。

市場動態：促進因素與限制因素

針刺傷次數增加

針刺傷害數量的增加預計將透過增加對安全注射器的需求以及將醫護人員的注意力從傳統注射器轉移到安全注射器來推動市場成長。

例如，根據 NIH 2022 年發布的一份報告，估計全球醫護人員每年發生 60 萬至 80 萬起針刺傷 (NSI) 和其他經皮損傷 (Pis)。

此外，根據 Becton Dickinson 2023 年提供的資料，預計每年有 38.5 萬名美國醫護人員和超過 100 萬名歐洲醫護人員因針頭或銳器意外而遭受經皮傷害。因此，針刺傷數量的增加預計將推動市場成長。

克制

與注射器相關的高成本

與傳統注射器相比，安全注射器的高成本預計將阻礙市場成長。高成本可能是由於所包含的安全功能所造成的。缺乏監管批准和替代藥物輸送系統的存在預計將阻礙市場成長。

Additionally, according to the data provided by Becton Dickinson in 2023, every year it is estimated that 385,000 healthcare workers in the United States and more than 1 million healthcare workers in Europe experience a percutaneous injury each year as a result of accidents with needles or sharps. Thus, an increase in the number of needlestick injuries is expected to drive the market growth.

Restraint

High costs associated with the syringes

The high costs of the safety syringes when compared to the conventional syringes are expected to hamper the market growth. The high cost can be due to the safety features that are incorporated. The lack of regulatory approvals and the presence of alternative drug delivery systems are expected to hamper the market growth.

Segment Analysis

The global safety syringes market is segmented based on product type, application, end-user and region.

Retractable safety syringes segment accounted for 39.8% of the market share

Retractable safety syringes are expected to hold a dominant share in the global safety syringes market share due to their advantages over the other types of safety syringes. The Retractable Safety Syringe works in just the same way as a classic syringe, but it automatically retracts the needle once the injection is completed.

They use a spring-loaded system or a manual system for retraction. They prevent cross-contamination and the spread of blood-borne infections. Manual retractable syringes are designed to prioritize safety and minimize the risk of needlestick injuries. Retractable needle safety syringes are mostly accepted over typical syringes and so possess substantial potential for growth. Thus, the retractable safety syringe segment is expected to hold the dominant share in the market.

Geographical Analysis

North America is expected to hold a significant position in the global safety syringes market share

North America holds a dominant share of the safety syringes market owing to the increase in the number of chronic diseases such as diabetes and tuberculosis in the region. The presence of a large number of medical device and disposables manufacturers is also expected to drive market growth in the region.

For instance, according to the report by the Pan American Health Organization in 2022, it is estimated that 62 million people of Americans are suffering from diabetes.

Safety insulin syringe where the needle retracts into the barrel of the syringe after administration, and lowers the risk of needlestick injury. A safety insulin syringe with a shield that slides over the needle lowers the risk of needlestick injury.

For instance, according to WHO, it is estimated that 10.6 million people who fall ill with TB worldwide in 2021 an increase of 4.5% from 10.1 million million in 2020. Thus, an increase in the number of chronic diseases is expected to drive the market growth.

COVID-19 Impact Analysis:

The COVID-19 has impacted the safety syringes market positively. With the increase in the number of vaccinations, the use of advanced safety syringes has been increased. The investments in safety syringe manufacturing have been increased. The vaccinations are made easy without any harm or infection to the patients with the safety syringes.

Competitive Landscape

The leading companies with a significant market share include: Becton Dickinson & Company, Thermo Fisher Scientific., Retractable Technologies, Inc., Terumo Corporation, Cardinal Health, B. Braun Melsungen AG, Revolutions Medical, NIPRO Medical Corporation, Sol-Millennium Inc., and AdvaCare Pharma among others.

Key Developments

On February 23, 2023, The FDA approved Zephyrus Innovations' Aeroject 3ml safety syringe which has an internal mechanism that retracts the needle inside the syringe after activation.
On October 11, 2021, Datwyler and Roncadelle developed a new safety syringe.

Why Purchase the Report?

To visualize the global safety syringes market segmentation based on product type, application, end-user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of safety syringes market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global safety syringes market report would provide approximately 59 tables, 61 figures, and 187 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increase in the number of needlestick injuries
  - 4.1.1.2.
- 4.1.2. Restraints
  - 4.1.2.1. High costs associated with the safety syringe
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Retractable Safety Syringes *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.2.3. Manual
- 7.2.4. Automatic
7.3. Non-Retractable Safety Syringes
- 7.3.1. Sliding Needle Cover Syringes
- 7.3.2. Sheathing Tube Syringes
- 7.3.3. Hinged Needle Cover Syringes

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Diabetes *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Tuberculosis
8.4. HIV
8.5. Hepatitis
8.6. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinics
9.4. Ambulatory Surgical Centers
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Becton Dickinson & Company *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Thermo Fisher Scientific.
12.3. Retractable Technologies, Inc.
12.4. Terumo Corporation
12.5. Cardinal Health
12.6. B. Braun Melsungen AG
12.7. Revolutions Medical
12.8. NIPRO Medical Corporation
12.9. Sol-Millennium Inc.
12.10. AdvaCare Pharma